Lou L - Search Results

1

Current challenges and the management of chronic hepatitis C in mainland China.

Duan Z, Jia JD, Hou J, Lou L, Tobias H, Xu XY, Wei L, Zhuang H, Pan CQ. Duan Z, et al. Among authors: lou l. J Clin Gastroenterol. 2014 Sep;48(8):679-86. doi: 10.1097/MCG.0000000000000109. J Clin Gastroenterol. 2014. PMID: 24921215 Free PMC article. Review.

2

Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.

Pan CQ, Trinh H, Yao A, Bae H, Lou L, Chan S; Study 123 Group. Pan CQ, et al. Among authors: lou l. PLoS One. 2014 Mar 4;9(3):e89789. doi: 10.1371/journal.pone.0089789. eCollection 2014. PLoS One. 2014. PMID: 24594870 Free PMC article. Clinical Trial.

3

Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.

Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Pan CQ, et al. Among authors: lou l. World J Gastroenterol. 2015 May 14;21(18):5524-31. doi: 10.3748/wjg.v21.i18.5524. World J Gastroenterol. 2015. PMID: 25987775 Free PMC article.

4

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

Marcellin P, Ahn SH, Ma X, Caruntu FA, Tak WY, Elkashab M, Chuang WL, Lim SG, Tabak F, Mehta R, Petersen J, Foster GR, Lou L, Martins EB, Dinh P, Lin L, Corsa A, Charuworn P, Subramanian GM, Reiser H, Reesink HW, Fung S, Strasser SI, Trinh H, Buti M, Gaeta GB, Hui AJ, Papatheodoridis G, Flisiak R, Chan HL; Study 149 Investigators. Marcellin P, et al. Among authors: lou l. Gastroenterology. 2016 Jan;150(1):134-144.e10. doi: 10.1053/j.gastro.2015.09.043. Epub 2015 Oct 8. Gastroenterology. 2016. PMID: 26453773 Free article. Clinical Trial.

5

Advances in Nucleotide Antiviral Development from Scientific Discovery to Clinical Applications: Tenofovir Disoproxil Fumarate for Hepatitis B.

Lou L. Lou L. J Clin Transl Hepatol. 2013 Sep;1(1):33-8. doi: 10.14218/JCTH.2013.004XX. Epub 2013 Sep 15. J Clin Transl Hepatol. 2013. PMID: 26357604 Free PMC article. Review.

6

Selected Thoughts on Hydrophobicity in Drug Design.

Lou LL, Martin JC. Lou LL, et al. Molecules. 2021 Feb 7;26(4):875. doi: 10.3390/molecules26040875. Molecules. 2021. PMID: 33562230 Free PMC article.

7

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.

Marcellin P, Buti M, Krastev Z, de Man RA, Zeuzem S, Lou L, Gaggar A, Flaherty JF, Massetto B, Lin L, Dinh P, Subramanian GM, McHutchison JG, Flisiak R, Gurel S, Dusheiko GM, Heathcote EJ. Marcellin P, et al. Among authors: lou l. J Hepatol. 2014 Dec;61(6):1228-37. doi: 10.1016/j.jhep.2014.07.019. Epub 2014 Jul 18. J Hepatol. 2014. PMID: 25046847 Free PMC article. Clinical Trial.

8

[No title available]

[No authors listed] [No authors listed] PMID: 35491556

9

Field evidence and modeling validation of biogeochemical controls on the deposition of persistent organic pollutants in the deep ocean.

Liu M, Zheng H, Li H, Chen F, Lou L, Wang W, Zhang H, Chen C, Ye J, Yan M, Leung KMY, Cai M. Liu M, et al. Among authors: lou l. J Hazard Mater. 2024 Nov 4;480:136395. doi: 10.1016/j.jhazmat.2024.136395. Online ahead of print. J Hazard Mater. 2024. PMID: 39549397

10

Identifying influencing factors and constructing a prediction model for long COVID-19 in hemodialysis patients.

Chen D, Li X, Xiao C, Xiao W, Lou L, Gao Z. Chen D, et al. Among authors: lou l. Int Urol Nephrol. 2024 Nov 11. doi: 10.1007/s11255-024-04276-2. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39527314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,036 results

Search Page

Filters